Delivery Order SPE2DB22D1017-SPE2DB25FF3RX

Award Date 1/22/25
Potential Completion Date 1/23/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB24D2109|SPE2DB25FHWCB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,092.16 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. Amerisourcebergen, a for-profit organization, is the prime contractor and there is no...
This federal contract award with ID SPE2DB20D1004|SPE2DB25FNECN was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,035.37 delivery order contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 14, 2025. This award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $1,838.16 and a performance period through April 11, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,795.66 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award, with ID SPE2DB20D3304|SPE2DB25FW5B8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price, is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product. The contract has a ceiling value of $4,700.18 and a completion date of January 15, 2025. This contract award is associated with a larger...
This federal contract award, valued at $1,150.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product used in the healthcare sector. The contract has a firm fixed-price pricing type and an ultimate completion date of January 31, 2025. This award is associated with Amerisourcebergen's...
This federal contract award, valued at $1,227.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a completion date of September 18, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $4,197.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product used in the treatment of diabetes. The contract has an ultimate completion date of January 8, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,262.17 firm-fixed-price delivery order has an ultimate completion date of April 26, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, with an ID of SPE2DB22D3501|SPE2DB24FVK56, was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the provision of 4564387967 NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has a ceiling value of $2,382.96, is a Delivery Order, and has a Firm Fixed Price pricing type. The award date is April 24, 2024, and the ultimate completion date is April 25,...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF3RX
    Delivery Order

This federal contract award, identified as SPE2DB22D1017|SPE2DB25FF3RX, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a ceiling value of $1,757.25. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of January 23, 2025 and was awarded on January 22, 2025. The place of performance is Conshohocken, PA 19428, USA. This contract award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the DLA Troop Support Medical. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/27/25, 1:00 AM